Kodak involved in SEC investigations of insider trading and breach of policy

It is alleged that information of a federal loan was released to the public before approval, which pushed its shares and some Kodak executives benefitted from it.



The US Securities and Exchange Commission (SEC) is looking into Eastman Kodak Co.’s handling of information regarding a massive federal drug loan of $765 million and possible insider trading of shares prior to its announcement.

The SEC is investigating allegations of wrongdoing, and whether or not Kodak violated disclosure requirements for publicly traded companies.

The agency is also investigating allegations of insider trading before the official loan announcement.

It is believed Kodak shared information on its deal with media outlets based in Rochester New York where it is headquartered. The news was later deleted on the company’s request. Generally, companies accompany such news with an embargo time and any breach can lead to repercussions.

A report by Reuters claimed that a day before the announcement, Kodak “granted its executive chairman options for 1.75 million shares as the result of what a person familiar with the arrangement described as an ‘understanding’ with its board that had previously neither been listed in his employment contract nor made public.”

Kodak Investigation Regulatory SEC

– Kodan HQ

Furthermore, new reports allege that Kodak CEO James Continenza purchased more than 46,000 shares days before the announcement. His profit from the purchase hit $1.6 million, the report said.

News of the loan caused Kodak shares to rise as high as $60, before falling to about $15 on Monday due to a dilution in the shares. Continenza, however, claimed he was unaware of any leaks in advance of the official announcement.

“I mean obviously this has been a pretty tight kept secret even until the last day,” Continenza told media.

A spokesperson for Kodak said that Continenza “has regularly purchased Kodak shares with his own money since joining the Company in 2013 … because he strongly believes in the long-term success of the Company.”

“In fact, Mr. Continenza has invested more capital in Kodak than he has earned during his tenure. Mr. Continenza has purchased shares at nearly every available window in which he is eligible since he joined the Company,” the spokesperson added. “He has not sold a single share of stock during his time at Kodak.”

Continenza emphasized that the loan announcement was in the works for about two months. He and Phillippe Katz, a board member and owner of several investment firms that hold Kodak shares, made purchases of Kodak shares during that time period, securities disclosures show.

The purchases were similar though smaller than earlier buyings, securities disclosures show.

The SEC investigation comes a day after Sen. Elizabeth Warren called the agency to look into “potential incidents of insider trading” related to the company’s deal with the government.

The Trump administration on its part has distanced itself from the Kodak deal, though an investigation has been promised to see what was involved.

SEC rules require public companies to adhere to all the norms and regulations to ensure accurate and timely disclosure of material events. Kodak, on the other hand defends itself by saying that the loan details aren’t finalized and that there is no guarantee one will be made.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

A report by blockchain data platform Chainalysis reveals that nearly $14 billion in cryptocurrency were sent to illicit addresses in 2021.
12 hours ago
Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Musk had previously revealed that he hopes the company will be able to address a wide range of neurological problems – ranging from addiction to paralysis.
1 day ago
Winter Olympics 2022: The Silence of the Brands

Winter Olympics 2022: The Silence of the Brands

Brands see the Olympics as an opportunity to connect with their consumers and boost sales with limited edition products.
2 days ago
Best Fintech Stocks to Buy in 2022

Best Fintech Stocks to Buy in 2022

The biggest names on Wall Street are buying some of these best fintech stocks of the year. Now maybe a great chance to invest money in the right business.
3 days ago
The Untold Story of How Elon Musk Ousted Tesla’s Founders

The Untold Story of How Elon Musk Ousted Tesla’s Founders

Not many know that Tesla wasn’t founded by Elon Musk. So who founded the world’s most valuable automotive company?
3 days ago
What’s the new inflation rate saying?

What’s the new inflation rate saying?

According to the US consumer price index, the inflation rate has witnessed a rapid rise during the past six months since it’s 0.8% increase in November.
4 days ago